Anesthesia Topics

TARGET AUDIENCE This course is designed for physicians, certified registered nurse anesthetists, physician assistants, registered nurses and other medical care providers who must maintain state-of-the-art knowledge of not only the specialty but also of all additional, related disciplines which may impact it. PROGRAM PURPOSE Presentations are designed to facilitate the physician, nurse specialist, and other providers maintaining skills of the same kind to review and update knowledge and ab...
Northwest Anesthesia Seminars

Topics in Anesthesia

TARGET AUDIENCE This course is designed for physicians, certified registered nurse anesthetists, physician assistants, registered nurses and other medical care providers who must maintain state-of-the-art knowledge of not only the specialty but also of all additional, related disciplines which may impact it. PROGRAM PURPOSE Presentations are designed to facilitate the physician, nurse specialist, and other providers maintaining skills of the same kind to review and update knowledge and ab...
Northwest Anesthesia Seminars

Anesthesia Update

TARGET AUDIENCE This course is designed for physicians, certified registered nurse anesthetists, physician assistants, registered nurses and other medical care providers who must maintain state-of-the-art knowledge of not only the specialty but also of all additional, related disciplines which may impact it. PROGRAM PURPOSE Presentations are designed to facilitate the physician, nurse specialist, and other providers maintaining skills of the same kind to review and update knowledge and ab...
Northwest Anesthesia Seminars

ACA | ACVP Annual Conference & Expo

BOOST YOUR PHARMACY’S SUCCESS! • Who Should Attend? Pharmacists, Pharmacy Owners, Pharmacy Technicians, Marketers, Pharmacy Students, Pharmacy Cooperatives and Buying Groups, Equipment and Chemical Suppliers, Finance, Insurance, Marketing, and Pharmacy Design Professionals. • Choose from 10 CE contact hours focusing on the hottest topics and trends in retail pharmacy today—including clinical, compounding, and veterinary compounding. • Ample networking opportunities with indep...
American College of Apothecaries

The Multidisciplinary Assessment and Management of CVD Risk in HIV Infection

This text-based interview is the second of a four-part series. Dr. Priscilla Hsue and Dr. E. Turner Overton discuss the multidisciplinary management of CVD risk in HIV-positive individuals. Discussion topics include risk assessment tools, and collaboration across the care team, including the role of PCPs and specialist referrals. HIV-infected individuals have an increased risk of CVD. Research has identified characteristics of HIV infection itself that influence CVD risks, yet their preci...
ACHL

Residual Neuromuscular Blockade - An Opportunity to Provide Optimal Patient Care Following Surgery

Residual neuromuscular blockade has been a long standing problem for post-surgical patients. Residual blockade is one of the many factors that may delay recovery and cause additional complications post-surgery. Implementation of Enhanced Recovery After Surgery (ERAS) protocols has been shown to improve peri- and post-operative care of the surgical patient. This program will provide an overview of the risks associated with residual neuromuscular blockade and discuss pharmaceutical options for r...
freeCE.com

Residual Neuromuscular Blockade - An Opportunity to Provide Optimal Patient Care Following Surgery

Residual neuromuscular blockade has been a long standing problem for post-surgical patients. Residual blockade is one of the many factors that may delay recovery and cause additional complications post-surgery. Implementation of Enhanced Recovery After Surgery (ERAS) protocols has been shown to improve peri- and post-operative care of the surgical patient. This program will provide an overview of the risks associated with residual neuromuscular blockade and discuss pharmaceutical options for r...
freeCE.com

Residual Neuromuscular Blockade - An Opportunity to Provide Optimal Patient Care Following Surgery

Residual neuromuscular blockade has been a long standing problem for post-surgical patients. Residual blockade is one of the many factors that may delay recovery and cause additional complications post-surgery. Implementation of Enhanced Recovery After Surgery (ERAS) protocols has been shown to improve peri- and post-operative care of the surgical patient. This program will provide an overview of the risks associated with residual neuromuscular blockade and discuss pharmaceutical options for r...
freeCE.com

Residual Neuromuscular Blockade - An Opportunity to Provide Optimal Patient Care Following Surgery

Residual neuromuscular blockade has been a long standing problem for post-surgical patients. Residual blockade is one of the many factors that may delay recovery and cause additional complications post-surgery. Implementation of Enhanced Recovery After Surgery (ERAS) protocols has been shown to improve peri- and post-operative care of the surgical patient. This program will provide an overview of the risks associated with residual neuromuscular blockade and discuss pharmaceutical options for r...
freeCE.com

How Sweet It Is! Management of Diabetes Series: Risk Reduction and Management of Complications with Diabetes Part 2

Patients with diabetes often turn to their pharmacist for assistance in smoking cessation, therefore pharmacists need to be knowledgeable in this area. Patients with diabetes also have questions about impotence and sexual intimacy, traveling with diabetes, and the management of pain.
freeCE.com

Clinical Overview of New Advances in Lipid Management, Hypertension & Bone & Joint Diseases

Session 1: What’s New with Lipid Management: Managing Statin Intolerance, Consensus Recommendations, New Evidence, and PCSK9 Inhibitors Session 2: What’s New with Hypertension: How Low to Go, New Evidence, Consensus Recommendations, and Treating Resistant Hypertension Session 3: What’s New in Bone and Joint Disease: Focus on drug Therapy Management for Gout, Osteoarthritis, and Bioidentical Medications for Rheumatoid Arthritis
University Learning Systems

Live CE/CME Conference aboard Alaska Cruise

Day 1: Pharmacogenomics : Guided therapy in Psychiatry, Cardiology and Oncology (5 hrs) Day 2: Transcranial Magnetic Stimulation-A novel FDA approved non invasive and non pharmacological treatment for Major Depressive Disorder (2.5 hrs) Day 3: Designer Drugs and Opioids: Identification of Patients who present with manifestation, screening tools, and management. (2.5 hrs) Day 4:Pediatric Autism Spectrum: An Overview (2 hrs) Drug Shortages and its Impact on Patient Safety and Medica...
University Learning Systems

Therapeutic Update 2018

Session 1: New Drug Update Part 1 Session 2: New Drug Update part 2 Session 3: To be determined
University Learning Systems

Therapeutic Update 2018 at Hyatt Regency Coconut Springs, Bonita Springs, FL

Session 1: New Drug Update, Part 1 Session 2: New Drug Update, Part 2 Session 3: To be determined
University Learning Systems

Depression, Anxiety, and Stress: Diagnosis, Pharmacotherapy and Non-Pharmacological Interventions - Western Caribbean Cruise 2018

Session 1: Depression: Diagnosis and Treatment Strategies Session 2: Anxiety: Diagnosis and Treatment Strategies Session 3: Stress and Trauma: Diagnosis and Treatment Strategies
University Learning Systems

From Provider To Patient: Opportunities and Dialogue for Appropriate Pain Management

This activity educates physicians, pharmacists, and other allied health personnel on the latest CDC guidelines surrounding prescription opioids as well as the latest epidemiological data surrounding addiction management and treatment. Multiple expert physicians trained in pain management as well as addiction management will discuss current best practices in both disciplines, while academic pharmacists will explain mechanisms of action, potential side effects, and regulatory issues surrounding ...
ACHL

From Provider To Patient: Opportunities and Dialogue for Appropriate Pain Management

This activity educates physicians, pharmacists, and other allied health personnel on the latest CDC guidelines surrounding prescription opioids as well as the latest epidemiological data surrounding addiction management and treatment. Multiple expert physicians trained in pain management as well as addiction management will discuss current best practices in both disciplines, while academic pharmacists will explain mechanisms of action, potential side effects, and regulatory issues surrounding ...
ACHL

From Psoriasis to Psoriatic Arthritis: Incorporating Advances to Individualize Treatment

Drs. Kenneth B. Gordon and Alexis Ogdie-Beatty facilitate a critical review and discuss up-to-date data impacting psoriasis and psoriatic arthritis (PsA) at the point of care. This activity is intended for dermatologists, rheumatologists, primary care physicians, nurse practitioners, pharmacists, and other affiliated providers involved in the diagnosis and treatment of patients with psoriasis and psoriatic arthritis. Upon completion of this activity, participants will be able to: • Ou...
ACHL/Purdue University College of Pharmacy

Updates in the Treatment and Prevention of C. difficile: Hospital Perspectives

This CME activity addresses hospital perspectives on C. difficile infection such as surveillance, preventive strategies and tailoring therapy to disease severity and patient factors. In this video-based interview, two faculty will discuss their approaches to the prevention and management of CDI and recurrent CDI in the hospital setting. This is the third in a series of five educational activities on CDI to be released in 2017. This activity is intended for gastroenterologists, infectious d...
ACHL

Hepatitis C(ured!:: Advances in the Management of Chronic Hepatitis C

Please note: If you are attending the program as part of alumni reunion weekend, please register at the alumni reunion weekend site: www.pharmacy.buffalo.edu/reunion2017 For all other general registrants, please register on this CE site. Live or via Webinar Friday, October 6th 443 Kapoor Hall, UB South Campus Program Agenda 10:00-10:30 AM : Registration & Refreshments 10:30-11:30 AM: Lecture, Q&A 11:30 AM: Continuing Education Verification, Evaluation, Adjournment Why Attend...
University at Buffalo School of Pharmacy

Pharmacists' Response to the Opioid Epidemic: Opioid Specific Counseling Wednesday Evening 9/13/17 Live & via Webinar

Live or via Webinar Wednesday Evening, Sept. 13th 125 Kapoor Hall, UB South Campus Program Agenda 5:30-6:00 pm: Registration & Refreshments 6:00-8:00 pm: Lecture, Q&A 8:00 pm: Continuing Education Verification, Evaluation, Adjournment Why Attend: It is estimated that 46 individuals die of prescription opioid overdoses every day in the United States. The Centers for Disease Control and Prevention reported that more than 16,000 individuals in the United States died of opioid over-d...
University at Buffalo School of Pharmacy

Familial Chylomicronemia Syndrome: Cause, Effect, and Solutions to Improve Patients' Quality-of-Life

Familial chylomicronemia syndrome (FCS) is a rare and potentially life-threatening genetic disease. The clinical hallmark of FCS is pancreatitis associated with marked chylomicronemia and triglyceridemia. It is important that gastroenterologists recognize the signs and symptoms to properly evaluate, as well as manage, patients with FCS. In this activity, a gastroenterologist will review the diagnosis, assessment, management, ongoing challenges, and future therapeutic options for patients with ...
Slack Inc.

Preventing Medical Errors for Clinical Health Professionals

This educational monograph addresses the identification, reporting, monitoring and reduction of medical error. It is intended to make participants aware of the magnitude of the problem, of the many-leveled activities needed to resolve it, and the importance of each person’s role in the national effort to reduce medical errors.
Slack Inc.

Back to the Future: Clinical Experience with and Access to Lipid-Lowering Agents of the Past, Present, and Future

With each passing year we gain new insight and understanding around the clinical utilization of lipid-lowering therapeutic agents. Our historical experience with older agents can often inform our knowledge and interpretation of how we view newly available options and those in development. How does our prior experience with statins and LDL-C lowering help us to better utilize and contextualize the newest classes of specialized high-intensity therapies? When do we consider off-label drug use ...
Slack Inc.

Integrating New Options Into Guideline-Directed Management of Heart Failure with Reduced Ejection Fraction

Heart failure (HF) is a chronic condition that requires long-term commitment on the part of the patient in adhering to an often-complex therapeutic and monitoring regimen, including lifestyle modifications and pharmacotherapy, and on the part of the clinician in maintaining knowledge to prescribe the most advantageous interventions. Although guidelines are widely available for the treatment of HF, gaps exist between these guidelines and actual care. Additionally, newly available remote monitor...
Slack Inc.

Collaborative Care Strategies for Reducing Hospital Readmissions in Patients with Heart Failure with Reduced Ejection Fraction

Heart failure (HF) is a chronic condition that requires long-term commitment on the part of the patient in adhering to an often-complex therapeutic and monitoring regimen, including lifestyle modifications and pharmacotherapy, and on the part of the clinician in maintaining knowledge of the most current therapies and devices to maximize efficacy, minimize side effects, improve monitoring, and reduce hospital readmissions. New treatments and technology have shown promise in improving outcomes i...
Slack Inc.

What You Need to Know About Familial Chylomicronemia Syndrome: Pathophysiology, Diagnosis, Management, and the Patient Perspective

Familial chylomicronemia syndrome (FCS) is a rare genetic disease that leads to severe hypertriglyceridemia and recurrent episodes of acute pancreatitis. Due to its rarity and nonspecific signs and symptoms, FCS is often hard to diagnose. Currently, there is a lack of effective treatments for patients with FCS, although several agents in development show promise. Cardiologists play a crucial role in the diagnosis and ongoing care of patients with FCS; thus, it is critical to improve knowledge ...
Slack Inc.

The Future of the Lipid Panel: An NLA Expert Discussion

Past-President of the National Lipid Association and Editor-in-Chief of the Journal of Clinical Lipidology, Dr. W. Virgil Brown is joined by Drs. Yehuda Handelsman, Pamela Morris, and Seth Martin to discuss new issues in lipoprotein management, including assessment of treatment targets, documenting and using new targets of treatment and the setting of goals-setting for these lipoprotein targets. This included the use of clinical trial data, and the feasibility of applying new laboratory measur...
Slack Inc.

Strategies for Preventing HIV-related Cardiovascular Disease

This text-based interview is the first of a four-part series. Dr. Chris Longenecker and Dr. Turner Overton address CVD risks in HIV-infected individuals, such as contributing factors for CVD (inflammation and immune activation), the impact of antiretroviral drug treatment (ART), risk factor modification, and ongoing clinical trials. HIV-infected individuals have an increased risk of CVD. Research has identified characteristics of HIV infection itself that influence CVD risks, yet their pre...
ACHL

The Immunosuppression Balancing Act: Preserving Long-Term Allograft Function for Optimal Patient Outcomes

The current goal of transplant medicine and immunology is to develop strategies to extend the life and functionality of every allograft. Outcomes of renal and liver transplantation have improved; yet, allograft loss remains a substantial problem associated with increased morbidity, mortality, and costs. Education to transplant clinicians about evaluating all aspects of post-transplant care, including regular monitoring, can lead to a reduction in allograft dysfunction or loss. In addition, ...
CME Outfitters, LLC

Integrated Care Strategies to Address the Impact of Residual Symptoms on Functional Outcomes in MDD

Depression is one of the leading causes of disability worldwide. It affects individuals, families, businesses, and society and is common in patients seeking care in the primary care setting. Approximately 55% of patients will respond to treatment with the initial antidepressant. Yet, even in those patients who respond to treatment and achieve remission, residual symptoms can significantly inhibit functionality and increase the risk of relapse and recurrence. Despite these challenges, MDD ca...
CME Outfitters, LLC

Deep Remission, Top-Down Treatment Strategies and Real-World Data in Patients with UC: An Interactive and Innovative Case Series

Ulcerative colitis (UC) is an inflammatory bowel disease with a progressive course characterized by exacerbations and remissions. Traditionally, the goals of therapy for UC have entailed resolution of clinical symptoms such as rectal bleeding, bloody diarrhea, abdominal cramps, pain, and fatigue. However, treatment goals for UC have evolved to a treat-to-target strategy with targets such as mucosal/endoscopic healing, histologic healing, or deep remission (i.e., clinical, biochemical, and endo...
CME Outfitters, LLC

Treating the Full Spectrum of Narcolepsy: Improving Nighttime Symptoms to Enhance Daytime Quality of Life: A Moderated Discussion with the Experts and Q&A

Patients with narcolepsy often face a long journey on their path to diagnosis and effective treatment. Combating the negative impact of narcolepsy on the lives of those affected requires that both the general public and the medical community increase their awareness of the symptoms of narcolepsy, in particular, the most common presenting symptoms: cataplexy and excessive daytime sleepiness. Improved recognition of both symptoms and objective measures of narcolepsy can shorten the burdensom...
CME Outfitters, LLC

From Symptom Recognition to Narcolepsy Diagnosis: Shortening the Diagnostic Journey: A Moderated Discussion with the Experts and Q&A

Patients with narcolepsy often face a long journey on their path to diagnosis and effective treatment. Combating the negative impact of narcolepsy on the lives of those affected requires that both the general public and the medical community increase their awareness of the symptoms of narcolepsy, in particular, the most common presenting symptoms: cataplexy and excessive daytime sleepiness. Improved recognition of both symptoms and objective measures of narcolepsy can shorten the burdensom...
CME Outfitters, LLC

Recognizing the Symptoms of Narcolepsy: Screening Your Sleepy Patient for Cataplexy: A Moderated Discussion with the Experts and Q&A

Patients with narcolepsy often face a long journey on their path to diagnosis and effective treatment. Combating the negative impact of narcolepsy on the lives of those affected requires that both the general public and the medical community increase their awareness of the symptoms of narcolepsy, in particular, the most common presenting symptoms: cataplexy and excessive daytime sleepiness. Improved recognition of both symptoms and objective measures of narcolepsy can shorten the burdensom...
CME Outfitters, LLC

Challenges in Patient Safety in Psychiatry

Patients with mental illness are at higher risk for adverse events including suicide, lack of medication adherence, and less likely to seek help during relapse. As pressure to discharge increases in addition to treatment plans, patients with mental illness must also have a safety plan beyond the length of hospitalization that makes the patient an equal participant and involves their entire care team, including family members. In this CME Outfitters Snack, expert faculty will discuss safety...
CME Outfitters, LLC

Advancing the Treatment of Focal Seizures in the Intensive Care Setting: A Multidisciplinary Team Approach

Seizures are a common occurrence in the intensive care setting with incidence estimates ranging from 3.3% to 34%. Encountering seizures in the intensive care unit (ICU) is frightening to patients and caregivers. Discharge orders that include new medication and possibly a new diagnosis—in addition to other orders or instructions can be daunting and confusing. Clinicians need strategies focused on the needs of the patients for optimal outcomes. Seizures occurring in the ICU require timely ...
CME Outfitters, LLC

Deep Remission, Mucosal Healing, and Top-Down Treatment Strategies in Ulcerative Colitis: An Infographic Journey

Ulcerative colitis (UC) is an inflammatory bowel disease with a progressive course characterized by exacerbations and remissions. Traditionally, the goals of therapy for UC have entailed resolution of clinical symptoms such as rectal bleeding, bloody diarrhea, abdominal cramps, pain, and fatigue. However, treatment goals for UC have evolved to a treat-to-target strategy with targets such as mucosal/endoscopic healing, histologic healing, or deep remission (i.e., clinical, biochemical, and endo...
CME Outfitters, LLC

Bringing Health Care Providers Together to Diagnose and Treat Idiopathic Pulmonary Fibrosis: A Patient Simulation

Although the most common of the restrictive lung diseases, idiopathic pulmonary fibrosis (IPF) is a rare but deadly disease, affecting an estimated 6.8 to 42.7 per 100,000 people, with higher rates in those older than 65 years, and resulting in approximately 40,000 deaths annually in the United States. Education to community pulmonologists, radiologists, and primary care physicians, as well as the multidisciplinary team is important to increase knowledge related to recognition and diagnosis...
CME Outfitters, LLC

Problem Based Learning in HBV: A Patient Simulation for Improving Treatment Decisions and Long-Term Care

Hepatitis B virus (HBV) infection is a largely undetected and untreated disease in the United States despite the availability of screening guidelines and prophylactic vaccines. Chronic HBV infection causes severe complications, including cirrhosis and hepatocellular carcinoma in 20% - 30% of patients. As a result, HBV infection is the most common reason for liver transplantation. While recommendations exist, primary care providers are not adequately screening at-risk patients for HBV infect...
CME Outfitters, LLC

Treating to Target in Patients with Gout and Chronic Kidney Disease: A Patient Simulation

Gout is the most common form of inflammatory arthritis in the United States. Hyperuricemia/gout in patients with CKD constitutes a significant burden for patients and society. Patients who are not managed adequately experience painful gout attacks, loss of function and productivity, and may develop long-term complications. The economic burden is also increased from patient utilization of prescription medication use, emergency room visits, and hospitalizations from gout or its serious complicat...
CME Outfitters, LLC

Selecting Appropriate Treatment for Patients With IPF: Applying Guidelines and Clinical Evidence

Although the most common of the restrictive lung diseases, idiopathic pulmonary fibrosis (IPF) is a rare but deadly disease, affecting an estimated 6.8 to 42.7 per 100,000 people, with higher rates in those older than 65 years, and resulting in approximately 40,000 deaths annually in the United States. Education to community pulmonologists, radiologists, and primary care physicians, as well as the multidisciplinary team is important to increase knowledge related to recognition and diagnosis...
CME Outfitters, LLC

Working Together to Diagnose IPF: A Multidisciplinary Approach

Although the most common of the restrictive lung diseases, idiopathic pulmonary fibrosis (IPF) is a rare but deadly disease, affecting an estimated 6.8 to 42.7 per 100,000 people, with higher rates in those older than 65 years, and resulting in approximately 40,000 deaths annually in the United States. Education to community pulmonologists, radiologists, and primary care physicians, as well as the multidisciplinary team is important to increase knowledge related to recognition and diagnosis...
CME Outfitters, LLC

Working Together to Diagnose IPF: Identifying the Signs and Symptoms

Although the most common of the restrictive lung diseases, idiopathic pulmonary fibrosis (IPF) is a rare but deadly disease, affecting an estimated 6.8 to 42.7 per 100,000 people, with higher rates in those older than 65 years, and resulting in approximately 40,000 deaths annually in the United States. Education to community pulmonologists, radiologists, and primary care physicians, as well as the multidisciplinary team is important to increase knowledge related to recognition and diagnosis...
CME Outfitters, LLC

Taking Action Against Chronic Hepatitis B Virus Infection: Determining Which Patients to Treat or Monitor

Hepatitis B virus (HBV) infection is a largely undetected and untreated disease in the United States. Only 33% of the estimated one million Americans living with HBV are aware that they are infected, placing them at risk for spreading the infection to others, and developing liver failure, cirrhosis, or hepatocellular carcinoma (HCC). As a result, HBV infection is the most common reason for liver transplantation. Primary care providers are not adequately screening at-risk patients for HBV in...
CME Outfitters, LLC

Taking Action Against Chronic Hepatitis B Virus Infection: Counseling Patients on Serological Results

Hepatitis B virus (HBV) infection is a largely undetected and untreated disease in the United States. Only 33% of the estimated one million Americans living with HBV are aware that they are infected, placing them at risk for spreading the infection to others, and developing liver failure, cirrhosis, or hepatocellular carcinoma (HCC). As a result, HBV infection is the most common reason for liver transplantation. Primary care providers are not adequately screening at-risk patients for HBV in...
CME Outfitters, LLC

Update on Indications, Interactions and Complications in the Use of Pharmaceuticals Western Mediterranean Cruise

Drug Abuse and Misuse (2 hrs) ◦ Identify the dangers associated with the nonmedical use of prescription and OTC medications. ◦ Devise ways to prevent medication abuse in your patients and drug diversion/mis-use within your practice. ◦Compare and contrast challenges with Prescription Drug Monitoring Programs and behind the counter status. ◦ Discuss the use of marijuana (and its active ingredients) for various medicinal purposes. Understanding Patient’s Approaches in Self...
Continuing Education, Inc

Medical Ethics and Legal Medicine Eastern Caribbean Cruise

LEGAL MEDICINE & MEDICAL ETHICS ◦WELCOME AND INTRODUCTION ◦ABLM-UAS Seminar Program ◦Welcome Cruise Seminar Attendees ◦Glossary of Legal Medicine Terms ◦ETHICS & BIOETHICS - 1 Hour ◦Medical Ethics Topics, Professionalism, and Communication ◦Ethics and Bioethics ◦Medscape Ethics Questionnaire ◦REGULATION OF MEDICAL PRACTICE - Overview of State and Federal Laws - 2 Hours ◦Medical Education and Licensing ◦Peer Review, Credentialing, and ...
Continuing Education, Inc

Infectious Diseases Cuban Cruise

1.Update Adult Vaccines ◦List vaccine preventable infections and their burden of disease ◦ List appropriate vaccines for adults ◦List strategies to increase uptake of adult vaccines 2.Antimicrobial Stewardship ◦List the benefits of stewardship for individual patients and the healthcare system ◦List interventions of effective stewardship 3.Update Respiratory Tract Infections ◦List common pathogens of RTIs ◦List appropriate management of RTIs 4.Update UTIs ...
Continuing Education, Inc

An Evolving Treatment Landscape for Inflammatory Disease: Debating Interchangeability, Efficacy, and Safety of Biosimilars

Health care spending has grown much faster than the rest of the economy, and this trend is seemingly unsustainable.1 Biologic agents are highly effective against inflammatory diseases, but may be restricted by many health care plans due to cost. Biosimilars offer a potential solution as a cost-effective alternative to biologic agents. Biosimilars have been available in Europe since 2005. In the United States, the first biosimilar monoclonal antibody, infliximab, was approved for rheumatoid art...
CME Outfitters, LLC

YouTube Google+ Pinterest Twitter LinkedIn Facebook SlideShare
RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.